IMMUNITRACK ApS: Financial statements 2022
CVR: 32347908
Source: annual report 2022, Danish Business Authority
01/06/2021 – 31/05/2022
IMMUNITRACK ApS (CVR 32347908) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 5,476,278 and a net result of DKK 1,175,601 compared with DKK 256,541 the year before. That is an increase of 20.8% compared with the year before. Equity in the 2022 report amounted to DKK 10,159,857. The solvency ratio was 65.3%. The company had 11 employees in the financial year.
- Gross Profit
- DKK 5,476,278
- Profit/Loss
- DKK 1,175,601
- Equity
- DKK 10,159,857
- Total Assets
- DKK 15,549,709
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 5.5 mio. | 1.2 mio. | 10.2 mio. | 11 |
| 2021 | - | 4.5 mio. | 257 t. | 7.7 mio. | 9 |
| 2020 | - | 1.1 mio. | -1.2 mio. | 4.9 mio. | 8 |
| 2019 | - | -457 t. | -2.3 mio. | 6.1 mio. | 6 |
| 2018 | - | 2.5 mio. | 1.7 mio. | 3.5 mio. | 4 |
Keep an eye on IMMUNITRACK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout IMMUNITRACK ApS
IMMUNITRACK ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company has been dissolved. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 6 employees (2018). In 2024, the company reported a gross profit of DKK 141,975,865 and a net result of DKK 110,009,470 compared with DKK -194,097 the year before. Equity in the 2024 report amounted to DKK 21,211,816.